Clinical genetic testing for neurological conditions has long been used in the pediatric population to identify genetic etiologies and inform medical management decisions; however, the utility in adult populations has not been well-explored. Previous studies regarding test utilization and diagnostic yield in a general adult neurological population are scarce and limited to a small cohort in one clinic. The purpose of this webinar is to review the findings of a recent research study analyzing the characteristics and detection rates of adult patients with neurological phenotypes undergoing genetic testing at a commercial laboratory.